Showing results (1-10 of 502) with videos related to
Sort By:
Pageof 51
Thrombosis and Haemostasis|October 28, 1987
Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI)J Gram, C Kluft, J JespersenThrombosis and Haemostasis|May 11, 1999
DNA-polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit--is there a relation with the low risk of cardiovascular disease in the Inuit?M P de Maat, E M Bladbjerg, L G Johansen, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 1997
The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitorsJ Sidelmann, J Jespersen, C Kluft, et al.American Journal of Clinical Pathology|June 1, 1985
Protection against venous thrombosis in an antithrombin-III deficient patient suffering from episodes of arterial thrombosis requiring major surgery. Effects of oral stanozolol in combination with subcutaneous heparin and intravenous AT-IIIJ Jespersen, J Gram, C Kluft, et al.Journal of Internal Medicine|October 1, 1990
Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endotheliumS Munkvad, J Jespersen, J Gram, et al.Journal of the American College of Cardiology|August 1, 1991
Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapyS Munkvad, J Jespersen, J Gram, et al.Journal of the American College of Cardiology|March 15, 1991
Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled studyS Munkvad, J Jespersen, J Gram, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 1997
Factor VII polymorphisms in populations with different risks of cardiovascular diseaseM P de Maat, F Green, P de Knijff, et al.Acta Medica Scandinavica|January 1, 1987
On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarctionJ Gram, J Jespersen, C Kluft, et al.Seminars in Thrombosis and Hemostasis|January 5, 2001
Fibrin clot formation and lysis: basic mechanismsJ J Sidelmann, J Gram, J Jespersen, et al.Pageof 51